Subscribe
7 April 2016Americas

DLA Piper adds partner and chair of FDA group

Law firm DLA Piper has hired James Czaban as a partner in the firm’s government affairs practice and chair of the firm’s US Food and Drug Administration group in Washington, DC.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

article
Why you shouldn’t overlook Canadian IP litigation
2 October 2017   Canada has a robust and reliable framework for resolving IP disputes, and it shouldn’t be ignored by litigants, say Ron Dimock, Sangeetha Punniyamoorthy and Nikolas Purcell of DLA Piper.
Americas
FDA clears orphan drug backlog
14 September 2017   The Food and Drugs Administration has cleared the backlog of orphan drug designation requests, one month early.
Americas
DLA Piper recruits life sciences lawyer for Silicon Valley
29 July 2014   DLA Piper has appointed life sciences lawyer Shane Albright to its corporate and finance practice.


Editor's picks

In-house with Bayer: ‘Focus on quality early and stay close to inventors’
Europe
In-house with Bayer: ‘Focus on quality early and stay close to inventors’
15 July 2025

Editor's picks

Europe
In-house with Bayer: ‘Focus on quality early and stay close to inventors’
15 July 2025

More on this story

article
Why you shouldn’t overlook Canadian IP litigation
2 October 2017   Canada has a robust and reliable framework for resolving IP disputes, and it shouldn’t be ignored by litigants, say Ron Dimock, Sangeetha Punniyamoorthy and Nikolas Purcell of DLA Piper.
Americas
FDA clears orphan drug backlog
14 September 2017   The Food and Drugs Administration has cleared the backlog of orphan drug designation requests, one month early.
Americas
DLA Piper recruits life sciences lawyer for Silicon Valley
29 July 2014   DLA Piper has appointed life sciences lawyer Shane Albright to its corporate and finance practice.

More on this story

article
Why you shouldn’t overlook Canadian IP litigation
2 October 2017   Canada has a robust and reliable framework for resolving IP disputes, and it shouldn’t be ignored by litigants, say Ron Dimock, Sangeetha Punniyamoorthy and Nikolas Purcell of DLA Piper.
Americas
FDA clears orphan drug backlog
14 September 2017   The Food and Drugs Administration has cleared the backlog of orphan drug designation requests, one month early.
Americas
DLA Piper recruits life sciences lawyer for Silicon Valley
29 July 2014   DLA Piper has appointed life sciences lawyer Shane Albright to its corporate and finance practice.

More features

AbbVie blocks Humira antitrust suit
WATCH: Enabling success—mastering s112 in the new era of life sciences patents
AstraZeneca suffers defeat over $7bn diabetes patent
US firm Brownstein nabs five from Crowell ‘at pivotal moment’
American Regent secures rare PI win in Hatch-Waxman dispute
WATCH: Patents s101—how to overcome the current complexity of patent eligibility in the US
In-house with Bayer: ‘Focus on quality early and stay close to inventors’
J&J sues over schizophrenia drug generic following patent victory